|
A feasibility analysis to align fit-for-purpose real-world (RW) data to emulate the AZUR-1 single-arm clinical trial in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) locally advanced rectal cancer (RC). |
| |
|
No Relationships to Disclose |
| |
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
| |
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
| |
|
No Relationships to Disclose |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
| |
|
Employment - GlaxoSmithKline |
| |
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
| |
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline; Pfizer |